Supriya Lifescience Profile
Key Indicators
- Authorised Capital ₹ 35.00 Cr
- Paid Up Capital ₹ 16.10 Cr
- Company Age 17 Year, 3 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 148.41 Cr
- Satisfied Charges ₹ 169.96 Cr
- Revenue Growth -12.50%
- Profit Growth -40.81%
- Ebitda -39.77%
- Net Worth 13.61%
- Total Assets 11.64%
About Supriya Lifescience
Supriya Lifescience Limited (SLL) is a leading Public Limited Indian Non-Government Company incorporated in India on 26 March 2008 and has a history of 17 years. Its registered office is in Mumbai, Maharashtra, India.
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 543434 and on the National Stock Exchange(NSE) under SUPRIYA.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 35.00 Cr and a paid-up capital of Rs 16.10 Cr.
The company currently has active open charges totaling ₹148.41 Cr. The company has closed loans amounting to ₹169.96 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Supriya Lifescience Limited India is Krishna Raghunathan as CFO. Dinesh Modi, Dileep Jain, Smita Wagh, and Seven other members serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
Industry
Pharma
What products or services does Supriya Lifescience Limited offer?
Supriya Lifescience Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Antiallergic API.
Who are the key members and board of directors at Supriya Lifescience?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Saloni Wagh  | Managing Director | 01-Jul-2022 | Current |
| Shivani Wagh | Managing Director | 01-Jul-2022 | Current |
| Krishna Raghunathan | CFO | 04-Apr-2023 | Current |
Board Members (8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Neelam Arora | Director | 25-Mar-2021 | Current |
| Dileep Jain | Director | 25-Mar-2021 | Current |
| Dinesh Modi | Director | 25-Mar-2021 | Current |
| Smita Wagh | Whole-Time Director | 26-Mar-2008 | Current |
| Satish Wagh | Whole-Time Director | 26-Mar-2008 | Current |
| Ganapathi Yadav | Additional Director | 24-Jan-2025 | Current |
Financial Performance of Supriya Lifescience.
Supriya Lifescience Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 12.5% decrease. The company also saw a substantial fall in profitability, with a 40.81% decrease in profit. The company's net worth Soared by an impressive increase of 13.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Supriya Lifescience?
In 2023, Supriya Lifescience had a promoter holding of 67.63% and a public holding of 32.38%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sachin Industries LimitedSatish Wagh is a mutual person
Rajasthan Consultancy Organisation LtdDileep Jain is a mutual person
Global Gsa Services India Private LimitedSatish Wagh is a mutual person
Federation Of Industries Of India-TmaSatish Wagh is a mutual person
Godrej Industries LimitedGanapathi Yadav is a mutual person
Aic Iiser Pune Seed FoundationSunil Bhagwat is a mutual person
Charges (Loans)
Open Charges
₹148.41 Cr
Satisfied Charges
₹169.96 Cr
Charges Breakdown by Lending Institutions
- Others : 87.00 Cr
- Axis Bank Limited : 44.00 Cr
- The Saraswat Cooperative Bank Ltd : 12.91 Cr
- The Saraswat Co-Op Bank Ltd : 4.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 May 2024 | Axis Bank Limited | ₹44.00 Cr | Open |
| 17 Apr 2024 | Others | ₹30.00 Cr | Open |
| 05 Jul 2012 | The Saraswat Cooperative Bank Ltd | ₹2.00 Cr | Open |
| 27 Jun 2009 | The Saraswat Cooperative Bank Ltd | ₹10.91 Cr | Open |
| 11 Jun 2009 | The Saraswat Co-Op Bank Ltd | ₹4.50 Cr | Open |
How Many Employees Work at Supriya Lifescience?
Supriya Lifescience has a workforce of 396 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Supriya Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Supriya Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Supriya Lifescience
Recent activity within the organization
- Director Appointment
Ganapathi Dadasaheb Yadav was appointed as a Additional Director was appointed as a Additional Director on 24 Jan 2025 & has been associated with this company since 2 months 5 days .
- Director Appointment
Sunil Subhash Bhagwat was appointed as a Additional Director was appointed as a Additional Director on 24 Jan 2025 & has been associated with this company since 2 months 5 days .
- Annual General Meeting
Supriya Lifescience Limited last Annual general meeting of members was held on 27 Sep 2024 as per latest MCA records.
- Charges
A charge with Axis Bank Limited amounted to Rs. 44.00 Cr with Charge ID 100916191 was registered on 03 May 2024.
- Charges
A charge registered on 10 May 2021 via Charge ID 100448146 with Others was fully satisfied on 26 Apr 2024.
- Charges
A charge with Others amounted to Rs. 30.00 Cr with Charge ID 100904329 was registered on 17 Apr 2024.
Recent News, Updates & Announcement
Supriya Lifesciences Q3 Results: Net profit triples to Rs 30 crore.Revenues rose 33% YoY to Rs 140 crore in Q3FY24. Earnings before interest, taxes, depreciation and amortisation (EBITDA) for Q3FY24 almost tripled to reach Rs. 41.49 crore, with an EBITDA margin of 29.6% in Q3FY24, as opposed to 13.4%, an improvement of 1620 basis points..
Frequently asked questions
What is the Incorporation or founding date of Supriya Lifescience Limited?
Supriya Lifescience Limited was incorporated on 26 Mar 2008.
What is authorized share capital and paid-up capital of Supriya Lifescience Limited?
The authorized share capital of Supriya Lifescience Limited is ₹ 35.00 Cr and paid-up capital is ₹ 16.10 Cr.
Who are the current board members & directors of Supriya Lifescience Limited?
Currently 11 directors are associated with Supriya Lifescience Limited.
- Dinesh Navnitlal Modi
- Dileep Kumar Jain
- Smita Satish Wagh
- Satish Waman Wagh
- Neelam Yashpal Arora
- Ganapathi Dadasaheb Yadav
- Balasaheb Gulabrao Sawant
- Saloni Satish Wagh
- Shivani Satish Wagh
- Sunil Subhash Bhagwat
- Krishna Raghunathan
What is the registered address of Supriya Lifescience Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Supriya Lifescience Limited is 207/208 Udyog Bhavan Sonawala Road Goregaon (East), India, Mumbai, Maharashtra, 400063.
What is the corporate identification number (CIN) and company number of Supriya Lifescience Limited?
The corporate identification number (CIN) of Supriya Lifescience Limited is L51900MH2008PLC180452 and the company number is 180452 as per Ministry of Corporate Affairs (MCA).
Is Supriya Lifescience Limited registered with any stock exchange in India?
Yes, Supriya Lifescience Limited is registered on Bombay Stock Exchange (BSE) and National Stock Exchange (NSE): SUPRIYA.
What is the official website of Supriya Lifescience Limited?
The Official website of Supriya Lifescience Limited is https://www.supriyalifescience.com
What has been the recent revenue trend for Supriya Lifescience Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Supriya Lifescience Limited has fallen by -12.50%.
How many employees does Supriya Lifescience Limited currently have?
As Per 2023 financial reports, 396 employees are currently employed by Supriya Lifescience Limited.
What change has been observed in the net worth of Supriya Lifescience Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Supriya Lifescience Limited has experienced an upsurge of 13.61%.
What are the total open charges for Supriya Lifescience Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Supriya Lifescience Limited amount to ₹ 148.41 Cr.
When was the last Balance Sheet of Supriya Lifescience Limited filed with the ROC?
The most recent Balance Sheet for Supriya Lifescience Limited was filed with the ROC on 31 Mar 2024.
People also Viewed
Bhairav ChokshiDirector
Kedar KarmarkarDirectorAW
Asha WaghWholetime DirectorAT
Ananda TawarDirectorMD
Manoj DorlikarWholetime Director